Table 2 Median (interquartile range) expression of markers ER, PgR, Ki67, p-Akt and p-Erk1/2 in samples A, B and C as defined in the text*
From: Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer
Marker | Sample A | Sample B | Sample C | Pvalue |
|---|---|---|---|---|
Ki67 | 16.4 (9.4-21.7) | 17.1 (7.0-25.1) | 15.3 (8.0-19.6) | 0.19 |
ER | 190.4 (171.2-200.5) | 194.7 (167.6-199.4) | 188.0 (145.1-195.4) | 0.06 |
PgR | 158.9 (58.3-193.3) | 161.0 (97.2-189.0) | 153.3 (42.2-193.2) | 0.89 |
HER2 | 3+: 1; 2+: 2; 1+: 14; 0: 4 | 3+: 1; 2+: 2; 1+: 13; 0: 4 | 3+: 1; 2+: 2; 1+: 3; 0: 15 | 0.0012 |
p-Akt | 111.4 (60.8-178.6) | 101.1 (75.4-146.0) | 26.8 (5.0-75.4) | <0.0001 |
p-Erk1/2 | 212.2 (123.6-243.6) | 193.1 (113.5-238.0) | 69.3 (0.4-113.5) | <0.0001 |